A global pharmaceutical company focused on women’s health, biosimilars, and a portfolio of established medicines that were largely spun out of Merck in 2021. Its products include contraception, fertility treatments, and legacy cardiovascular and respiratory drugs that generate steady cash flow acros...
4 members of Congress have disclosed 13 trades in Organon & Co. (OGN), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-08-26 | Rohit Khanna | buy | $1K – $15K |
| 2023-12-04 | Rohit Khanna | buy | $1K – $15K |
| 2023-11-03 | Rohit Khanna | sell | $1K – $15K |
| 2023-10-02 | Rohit Khanna | buy | $1K – $15K |
| 2023-07-28 | Rohit Khanna | buy | $1K – $15K |
| 2023-06-29 | Rohit Khanna | sell | $1K – $15K |
| 2022-08-02 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2022-05-13 | Rohit Khanna | buy | $1K – $15K |
| 2022-04-13 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2021-06-28 | John W Hickenlooper | sell | $1K – $15K |
| 2021-06-08 | Scott Franklin | sell | $1K – $15K |
| 2021-06-08 | Scott Franklin | sell | $15K – $50K |
| 2021-03-17 | MICHAEL T. MCCAUL | sell | $15K – $50K |